Patents by Inventor Jingrong Wang

Jingrong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIGHTWEIGHT GEL SLEEVE
    Publication number: 20230363548
    Abstract: The present invention discloses a lightweight gel sleeve, which comprises a top gel layer, a bottom gel layer and a lateral gel layer, wherein the top gel layer defines a middle cavity, and the lateral gel layer extends upward from the outer edge of the bottom gel layer to connect the bottom gel layer to the top gel layer; the top gel layer, the bottom gel layer and the lateral gel layer enclose an internal space, and the bottom gel layer defines a central opening communicated with the internal space through the gel layers, the central opening provides a passage through the gel layers and the internal space, and the top gel layer, the bottom gel layer and the lateral gel layer are integrally formed.
    Type: Application
    Filed: April 11, 2023
    Publication date: November 16, 2023
    Inventor: Jingrong Wang
  • Method and compounds for inhibiting the MCM complex and their application in cancer treatment
    Publication number: 20230293564
    Abstract: A method for treating cancer by using an agent which is capable of inhibiting the functionality of the MCM complex, a heterohexameric ring formed from six subunits, in the process of DNA replication and a method of screening for such agents by detecting the locations and functions of the MCM subunits, such as hMcm2 and hMcm6, in cells treated with candidate compounds.
    Type: Application
    Filed: April 17, 2023
    Publication date: September 21, 2023
    Applicants: The Hong Kong University Of Science And Technology, Hong Kong Baptist University, Macau University Of Science And Technology
    Inventors: Chun LIANG, Zhihong JIANG, Ziyi Wang, Zhiling Yu, Jingrong Wang, Liping Bai
  • Method and compounds for inhibiting the MCM complex and their application in cancer treatment
    Patent number: 11648258
    Abstract: A method for treating cancer by using an agent which is capable of inhibiting the functionality of the MCM complex, a heterohexameric ring formed from six subunits, in the process of DNA replication and a method of screening for such agents by detecting the locations and functions of the MCM subunits, such as hMcm2 and hMcm6, in cells treated with candidate compounds.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: May 16, 2023
    Assignees: The Hong Kong University Of Science And Technology, Hong Kong Baptist University, Macau University Of Science And Technology
    Inventors: Chun Liang, Zhihong Jiang, Ziyi Wang, Zhiling Yu, Jingrong Wang, Liping Bai
  • Compounds and methods for treating influenza
    Patent number: 11377418
    Abstract: A compound including a structure of Formula (I) and a preparation method thereof, wherein R1 is —OH, —CH2OH, or —OCOCH3; R2, R3, and R4 are independently —H, —CH3 or —F, and at least one of R2, R3, and R4 is —F. A method for treating a subject suffering from a viral disease includes administering an effective amount of said compound or a solvate thereof to the subject.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: July 5, 2022
    Assignee: Macau University of Science and Technology
    Inventors: Zhi-Hong Jiang, Nanshan Zhong, Zifeng Yang, Jingrong Wang, Qitong Feng, Xiaobo Zhou, Beixian Zhou
  • COMPOUNDS AND METHODS FOR TREATING INFLUENZA
    Publication number: 20220127220
    Abstract: A compound including a structure of Formula (I) and a preparation method thereof, wherein R1 is —OH, —CH2OH, or —OCOCH3; R2, R3, and R4 are independently —H, —CH3 or —F, and at least one of R2, R3, and R4 is —F. A method for treating a subject suffering from a viral disease includes administering an effective amount of said compound or a solvate thereof to the subject.
    Type: Application
    Filed: December 3, 2020
    Publication date: April 28, 2022
    Inventors: Zhi-Hong Jiang, Nanshan Zhong, Zifeng Yang, Jingrong Wang, Qitong Feng, Xiaobo Zhou, Beixian Zhou
  • Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
    Patent number: 9561223
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
    Patent number: 9561222
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
    Patent number: 9561219
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
    Patent number: 9561220
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of alkaloids, the novel autophagic enhancers for treatment of cancers and neurodegenerative conditions thereof
    Patent number: 9561221
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160113922
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 28, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160106730
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160106733
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160106729
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160106734
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20160106732
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury
    Patent number: 9273088
    Abstract: The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: March 1, 2016
    Assignee: Macau University of Science and Technology
    Inventors: Jingrong Wang, Pei Luo, Hua Zhou, Wai In Chan, Liang Liu, Zhihong Jiang
  • Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions Thereof
    Publication number: 20150190392
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 8, 2014
    Publication date: July 9, 2015
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Novel Ginsenoside Derivative Compounds And The Use Thereof In Protection Against Ischemia/Reperfusion Injury
    Publication number: 20150112048
    Abstract: The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury.
    Type: Application
    Filed: October 17, 2013
    Publication date: April 23, 2015
    Applicant: Macau University of Science and Tehnology
    Inventors: Jingrong WANG, Pei LUO, Hua ZHOU, Wai In CHAN, Liang LIU, Zhihong JIANG
  • METHOD AND COMPOUNDS FOR INHIBITING THE MCM COMPLEX AND THEIR APPLICATION IN CANCER TREATMENT
    Publication number: 20150099712
    Abstract: A method for treating cancer by using an agent which is capable of inhibiting the functionality of the MCM complex, a heterohexameric ring formed from six subunits, in the process of DNA replication and a method of screening for such agents by detecting the locations and functions of the MCM subunits, such as hMcm2 and hMcm6, in cells treated with candidate compounds.
    Type: Application
    Filed: May 9, 2013
    Publication date: April 9, 2015
    Inventors: Chun Liang, Zhihong Jiang, Ziyi Wang, Zhiling Yu, Jingrong Wang, Liping Bai